Skip to search formSkip to main contentSkip to account menu

TLC ELL-12

Known as: 1-0-Octadecyl-2-O-methyl-Sn-3-glycero-phosphocholine Liposome, ELL-12 
A liposomal formulation of the ether lipid 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with potential antineoplastic activity. TLC ELL-12… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

edelfosine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
TLC ELL-12: Oncolytic
1999
1999
Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling.
ELL-12, a liposome formulation of the ether-lipid 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH(3)), is a… 
1999
1999
Differential effects of free and liposome‐associated 1‐O‐octadecyl‐2‐O‐methylglycerophosphocholine on protein kinase C
1999
1999
P13 Liposome-associated 1-O-octadecyl-2-O-methyl-sn-3-phosphocholine cell (ELL-12) inhibits growth of a mouse melanoma
1997
1997
Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
The ether-lipid 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH3) has anticancer activity, but systemic toxicity… 
1997
1997
Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine
The growth inhibitory effects of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine (ET-18-OCH3) and various liposome… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)